Article Name Medtech innovation
Vystar plans to apply Fluid Energy Conversion (FEC) technology to increase pathogen killing efficiency, reduce the size and cost of Vystar’s RxAir air purifiers
30th January, 2026
The Company expects to launch Eversense 365 in Germany, Italy, Spain and Sweden in the coming months
30th January, 2026
Ready-to-use preformed antibiotic-loaded spacers for hip, knee and shoulder revisions
29th January, 2026
The contract includes the delivery and installation of a Proteus ONE system as well as a comprehensive Quality Assurance package from IBA Dosimetry
27th January, 2026
BD has now expanded the platform with new three- and four-laser configurations, aimed at broadening access to advanced spectral and imaging technologies for laboratories with diverse scales, budgets, and research priorities
27th January, 2026
The patent's focus on a constant-slope transition ensures a gradual and predictable stiffness profile
23rd January, 2026
Polarean’s Xenon MRI platform is opening a new window into the pulmonary microvasculature, long considered a “silent zone” in cardiopulmonary disease and reshaping how pharma sponsors evaluate therapeutic response
23rd January, 2026
The Medtech Incubator–Leap partnership seeks to streamline this process by delivering not just new devices, but supported, compliant, and operationally ready launches
23rd January, 2026
MFUSE is designed to support clinicians in managing external bleeding by forming a flexible hydrogel barrier when applied to the wound site
21st January, 2026
Polarean is working in collaboration with VIDA Diagnostics (VIDA), providing centralised imaging operations, site orchestration, and advanced Xenon MRI biomarker analysis
21st January, 2026
CART is positioning cuffless monitoring as a credible alternative to traditional 24-hour ambulatory devices
21st January, 2026
Researchers develop an innovative dural patch that achieves rapid, watertight sealing of dural tears, boasting high biocompatibility
19th January, 2026
Combines AI-powered technology with R1 experts to set a new standard for clearance and denial rates
16th January, 2026
The investment - which is a substantial contribution from Verdane's €2 billion growth fund - is the single largest investment in Clue
15th January, 2026
The Breakthrough Device Designation is a distinction reserved for technologies that offer a more effective treatment or diagnosis for life-threatening or irreversibly debilitating diseases
14th January, 2026
Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into pregnancy health
13th January, 2026
Dr Govindarajan also shares insights into workflow integration, change management at scale
13th January, 2026
New capabilities enable Teladoc Health’s care teams to address a broader spectrum of health needs, delivering more value in virtual urgent care visits
12th January, 2026
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer